Lévitation diamagnétique sur micro-aimants : applications à la microfluidique digitale et à la biologie.

Diamagnetic levitation is one of the rare way to compensate action of gravity. This kind of repulsion is negligible at our scale. However, at microscale, this effect becomes significant and can achieve levitation of diamagnetic objects. Through the development of micromagnets of numerical and analytical models as well as experimental achievements , these works explore the potential of diamagnetic levitation microdroplets and particles in a paramagnetic environment. They especially demonstrate the ability to accurately measure the interaction between charged droplets levitated . These studies analyze further the study of this levitation combined with dielectrophoretic force . This study opens new perspectives for sorting diamagnetic ball based on their size or susceptibility. Dielectrophoresis opens possibilities in the field for actuating contactless microbeads levitated.La lévitation diamagnétique est un des rares phénomènes permettant de soustraire des corps à la gravité. Si la répulsion diamagnétique est négligeable à nos échelles, elle devient significative aux petites dimensions, allant jusqu’à entraîner, sous certaines conditions, la mise en lévitation de micro-objets diamagnétiques. A travers le développement de microaimants, de modèles numériques et analytiques ainsi que de réalisations expérimentales, ces travaux explorent les potentialités de la lévitation diamagnétique de microgouttes et de particules dans un milieu paramagnétique. Ils démontrent notamment la possibilité de mesurer précisément l’interaction entre gouttes chargées en lévitation. Ces travaux analysent par ailleurs l’étude de cette lévitation combinée à une force diélectrophorétique. Cette étude ouvre de nouvelles perspectives pour le tri de bille diamagnétique basé sur leur taille ou leur susceptibilité. La diélectrophorèse ouvre le champ des possibilités en permettant d’actionner sans contact des micro-billes mises en lévitation

Lévitation diamagnétique sur micro-aimants (applications à la microfluidique digitale et à la biologie.)

La lévitation diamagnétique est un des rares phénomènes permettant de soustraire des corps à la gravité. Si la répulsion diamagnétique est négligeable à nos échelles, elle devient significative aux petites dimensions, allant jusqu à entraîner, sous certaines conditions, la mise en lévitation de micro-objets diamagnétiques. A travers le développement de microaimants, de modèles numériques et analytiques ainsi que de réalisations expérimentales, ces travaux explorent les potentialités de la lévitation diamagnétique de microgouttes et de particules dans un milieu paramagnétique. Ils démontrent notamment la possibilité de mesurer précisément l interaction entre gouttes chargées en lévitation. Ces travaux analysent par ailleurs l étude de cette lévitation combinée à une force diélectrophorétique. Cette étude ouvre de nouvelles perspectives pour le tri de bille diamagnétique basé sur leur taille ou leur susceptibilité. La diélectrophorèse ouvre le champ des possibilités en permettant d actionner sans contact des micro-billes mises en lévitation.Diamagnetic levitation is one of the rare way to compensate action of gravity. This kind of repulsion is negligible at our scale. However, at microscale, this effect becomes significant and can achieve levitation of diamagnetic objects. Through the development of micromagnets of numerical and analytical models as well as experimental achievements , these works explore the potential of diamagnetic levitation microdroplets and particles in a paramagnetic environment. They especially demonstrate the ability to accurately measure the interaction between charged droplets levitated . These studies analyze further the study of this levitation combined with dielectrophoretic force . This study opens new perspectives for sorting diamagnetic ball based on their size or susceptibility. Dielectrophoresis opens possibilities in the field for actuating contactless microbeads levitated.SAVOIE-SCD - Bib.électronique (730659901) / SudocGRENOBLE1/INP-Bib.électronique (384210012) / SudocGRENOBLE2/3-Bib.électronique (384219901) / SudocSudocFranceF

Características hidro-planctónicas y su relación con las distribuciones de sardina y anchoa en la plataforma francesa del Golfo de Vizcaya

The spatial pattern in hydro-plankton and fish distributions and their relationship were analysed based on the spring 2000 fisheries acoustic survey. The importance of this survey was that it was a multi-disciplinary platform which collected an extensive set of parameters in the hydro-plankton leading to a potentially finer description of hydro-plankton conditions and fish habitats. More than 50 variables were measured on a grid of stations, in four compartments of the ecosystem: hydrology, nutrients, primary producers and meso-zooplankton. First, a joint analysis of all hydro-plankton compartments was performed using multiple factor analysis (MFA). The method was used to estimate a compromise factorial space common to all compartments in which the stations were grouped by hierarchical clustering. The groups were represented spatially and a strong spatial pattern was evidenced. The fish and their spawned eggs were sampled along transect lines using acoustics and CUFES (continuous underway fish egg samplers). The distribution of the fish and their eggs was analysed in relation to the hydro-plankton groups of stations and difference in fish density across hydro-plankton conditions was tested by a pair-wise multiple comparison procedure. Anchovy was associated with a lesser number of hydro-plankton conditions than sardine. Eggs of both species were also associated with a lesser number of conditions than the fish. Finally, the gain provided by using the extensive set of hydro-plankton parameters for mapping large-scale hydro-plankton conditions was analysed in comparison with the situation in which a small set of parameters was available. The extensive set of parameters allowed more hydro-plankton conditions to be identified but only in the coastal area and not on the shelf. Size fractionated chlorophyll was determinant for tracking river plume hydro-plankton condition. However, the fish did not respond to the variety of the coastal hydro-plankton conditions.Este artículo analiza la relación espacial entre los peces pelágicos y su medio ambiente utilizando datos de la campaña acústica francesa del año 2000. Esta campaña fue multidisciplinaria y permitió la colección de una lista extensa de parámetro en el hidro-plancton. Mas de 50 variables fueron muestreadas sobre la misma red de estaciones. Estas variables se agrupan en cuatro compartimientos del ecosistema: hidrología, nutrientes y materia en suspensión, bacterias y fitoplancton, mesozooplancton. En primer lugar se hizo una análisis conjunto a todas las variables reagrupadas en los cuatros compartimientos aplicando el método MFA (Análisis Factorial Múltiple). El método permitió estimar el espacio factorial común a todos los compartimientos en el que se hizo un agrupamiento de las estaciones. Los grupos tenían una distribución espacial bien estructurada. Durante la campaña, los peces fueron muestreados sobre líneas de muestreo usando el método acústico y sus huevos fueron muestreado al mismo tiempo con la bomba CUFES (continuous underway fish egg sampler). Las diferencias de abundancia de peces y de sus huevos, relativas a los grupos del hidro-plancton, se comprobaron estadísticamente. La anchoa estaba limitada a grupos de hidro-plancton particulares mientras que la sardina no lo estaba. Las puestas de las dos especies estaban limitadas a menos grupos que los adultos. El beneficio de usar una lista extensiva de variables en el hidro-plancton fue analizado. La clorofila por clases de tamaño era determinante en identificar grupos de hidro-plancton relacionados con las plumas de los ríos. Pero el pez no estaba relacionado solamente con estos grupos

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.

Importance: Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19) is limited. Objective: To determine whether hydrocortisone improves outcome for patients with severe COVID-19. Design, Setting, and Participants: An ongoing adaptive platform trial testing multiple interventions within multiple therapeutic domains, for example, antiviral agents, corticosteroids, or immunoglobulin. Between March 9 and June 17, 2020, 614 adult patients with suspected or confirmed COVID-19 were enrolled and randomized within at least 1 domain following admission to an intensive care unit (ICU) for respiratory or cardiovascular organ support at 121 sites in 8 countries. Of these, 403 were randomized to open-label interventions within the corticosteroid domain. The domain was halted after results from another trial were released. Follow-up ended August 12, 2020. Interventions: The corticosteroid domain randomized participants to a fixed 7-day course of intravenous hydrocortisone (50 mg or 100 mg every 6 hours) (n = 143), a shock-dependent course (50 mg every 6 hours when shock was clinically evident) (n = 152), or no hydrocortisone (n = 108). Main Outcomes and Measures: The primary end point was organ support-free days (days alive and free of ICU-based respiratory or cardiovascular support) within 21 days, where patients who died were assigned -1 day. The primary analysis was a bayesian cumulative logistic model that included all patients enrolled with severe COVID-19, adjusting for age, sex, site, region, time, assignment to interventions within other domains, and domain and intervention eligibility. Superiority was defined as the posterior probability of an odds ratio greater than 1 (threshold for trial conclusion of superiority >99%). Results: After excluding 19 participants who withdrew consent, there were 384 patients (mean age, 60 years; 29% female) randomized to the fixed-dose (n = 137), shock-dependent (n = 146), and no (n = 101) hydrocortisone groups; 379 (99%) completed the study and were included in the analysis. The mean age for the 3 groups ranged between 59.5 and 60.4 years; most patients were male (range, 70.6%-71.5%); mean body mass index ranged between 29.7 and 30.9; and patients receiving mechanical ventilation ranged between 50.0% and 63.5%. For the fixed-dose, shock-dependent, and no hydrocortisone groups, respectively, the median organ support-free days were 0 (IQR, -1 to 15), 0 (IQR, -1 to 13), and 0 (-1 to 11) days (composed of 30%, 26%, and 33% mortality rates and 11.5, 9.5, and 6 median organ support-free days among survivors). The median adjusted odds ratio and bayesian probability of superiority were 1.43 (95% credible interval, 0.91-2.27) and 93% for fixed-dose hydrocortisone, respectively, and were 1.22 (95% credible interval, 0.76-1.94) and 80% for shock-dependent hydrocortisone compared with no hydrocortisone. Serious adverse events were reported in 4 (3%), 5 (3%), and 1 (1%) patients in the fixed-dose, shock-dependent, and no hydrocortisone groups, respectively. Conclusions and Relevance: Among patients with severe COVID-19, treatment with a 7-day fixed-dose course of hydrocortisone or shock-dependent dosing of hydrocortisone, compared with no hydrocortisone, resulted in 93% and 80% probabilities of superiority with regard to the odds of improvement in organ support-free days within 21 days. However, the trial was stopped early and no treatment strategy met prespecified criteria for statistical superiority, precluding definitive conclusions. Trial Registration: ClinicalTrials.gov Identifier: NCT02735707

TRY plant trait database – enhanced coverage and open access

Plant traits - the morphological, anatomical, physiological, biochemical and phenological characteristics of plants - determine how plants respond to environmental factors, affect other trophic levels, and influence ecosystem properties and their benefits and detriments to people. Plant trait data thus represent the basis for a vast area of research spanning from evolutionary biology, community and functional ecology, to biodiversity conservation, ecosystem and landscape management, restoration, biogeography and earth system modelling. Since its foundation in 2007, the TRY database of plant traits has grown continuously. It now provides unprecedented data coverage under an open access data policy and is the main plant trait database used by the research community worldwide. Increasingly, the TRY database also supports new frontiers of trait‐based plant research, including the identification of data gaps and the subsequent mobilization or measurement of new data. To support this development, in this article we evaluate the extent of the trait data compiled in TRY and analyse emerging patterns of data coverage and representativeness. Best species coverage is achieved for categorical traits - almost complete coverage for ‘plant growth form’. However, most traits relevant for ecology and vegetation modelling are characterized by continuous intraspecific variation and trait–environmental relationships. These traits have to be measured on individual plants in their respective environment. Despite unprecedented data coverage, we observe a humbling lack of completeness and representativeness of these continuous traits in many aspects. We, therefore, conclude that reducing data gaps and biases in the TRY database remains a key challenge and requires a coordinated approach to data mobilization and trait measurements. This can only be achieved in collaboration with other initiatives

Carbone des sols en Afrique

Les sols sont une ressource essentielle à préserver pour la production d’aliments, de fibres, de biomasse, pour la filtration de l’eau, la préservation de la biodiversité et le stockage du carbone. En tant que réservoirs de carbone, les sols sont par ailleurs appelés à jouer un rôle primordial dans la lutte contre l’augmentation de la concentration de gaz à effet de serre. Ils sont ainsi au centre des objectifs de développement durable (ODD) des Nations unies, notamment les ODD 2 « Faim zéro », 13 « Lutte contre le changement climatique », 15 « Vie terrestre », 12 « Consommation et production responsables » ou encore 1 « Pas de pauvreté ». Cet ouvrage présente un état des lieux des sols africains dans toute leur diversité, mais au-delà, il documente les capacités de stockage de carbone selon les types de sols et leurs usages en Afrique. Il propose également des recommandations autour de l’acquisition et de l’interprétation des données, ainsi que des options pour préserver, voire augmenter les stocks de carbone dans les sols. Tous les chercheurs et acteurs du développement impliqués dans les recherches sur le rôle du carbone des sols sont concernés par cette synthèse collective. Fruit d’une collaboration entre chercheurs africains et européens, ce livre insiste sur la nécessité de prendre en compte la grande variété des contextes agricoles et forestiers africains pour améliorer nos connaissances sur les capacités de stockage de carbone des sols et lutter contre le changement climatique

Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome associated with COVID-19: An Emulated Target Trial Analysis.

RATIONALE: Whether COVID patients may benefit from extracorporeal membrane oxygenation (ECMO) compared with conventional invasive mechanical ventilation (IMV) remains unknown. OBJECTIVES: To estimate the effect of ECMO on 90-Day mortality vs IMV only Methods: Among 4,244 critically ill adult patients with COVID-19 included in a multicenter cohort study, we emulated a target trial comparing the treatment strategies of initiating ECMO vs. no ECMO within 7 days of IMV in patients with severe acute respiratory distress syndrome (PaO2/FiO2 <80 or PaCO2 ≥60 mmHg). We controlled for confounding using a multivariable Cox model based on predefined variables. MAIN RESULTS: 1,235 patients met the full eligibility criteria for the emulated trial, among whom 164 patients initiated ECMO. The ECMO strategy had a higher survival probability at Day-7 from the onset of eligibility criteria (87% vs 83%, risk difference: 4%, 95% CI 0;9%) which decreased during follow-up (survival at Day-90: 63% vs 65%, risk difference: -2%, 95% CI -10;5%). However, ECMO was associated with higher survival when performed in high-volume ECMO centers or in regions where a specific ECMO network organization was set up to handle high demand, and when initiated within the first 4 days of MV and in profoundly hypoxemic patients. CONCLUSIONS: In an emulated trial based on a nationwide COVID-19 cohort, we found differential survival over time of an ECMO compared with a no-ECMO strategy. However, ECMO was consistently associated with better outcomes when performed in high-volume centers and in regions with ECMO capacities specifically organized to handle high demand. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/)

The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance

INTRODUCTION Investment in Africa over the past year with regard to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing has led to a massive increase in the number of sequences, which, to date, exceeds 100,000 sequences generated to track the pandemic on the continent. These sequences have profoundly affected how public health officials in Africa have navigated the COVID-19 pandemic. RATIONALE We demonstrate how the first 100,000 SARS-CoV-2 sequences from Africa have helped monitor the epidemic on the continent, how genomic surveillance expanded over the course of the pandemic, and how we adapted our sequencing methods to deal with an evolving virus. Finally, we also examine how viral lineages have spread across the continent in a phylogeographic framework to gain insights into the underlying temporal and spatial transmission dynamics for several variants of concern (VOCs). RESULTS Our results indicate that the number of countries in Africa that can sequence the virus within their own borders is growing and that this is coupled with a shorter turnaround time from the time of sampling to sequence submission. Ongoing evolution necessitated the continual updating of primer sets, and, as a result, eight primer sets were designed in tandem with viral evolution and used to ensure effective sequencing of the virus. The pandemic unfolded through multiple waves of infection that were each driven by distinct genetic lineages, with B.1-like ancestral strains associated with the first pandemic wave of infections in 2020. Successive waves on the continent were fueled by different VOCs, with Alpha and Beta cocirculating in distinct spatial patterns during the second wave and Delta and Omicron affecting the whole continent during the third and fourth waves, respectively. Phylogeographic reconstruction points toward distinct differences in viral importation and exportation patterns associated with the Alpha, Beta, Delta, and Omicron variants and subvariants, when considering both Africa versus the rest of the world and viral dissemination within the continent. Our epidemiological and phylogenetic inferences therefore underscore the heterogeneous nature of the pandemic on the continent and highlight key insights and challenges, for instance, recognizing the limitations of low testing proportions. We also highlight the early warning capacity that genomic surveillance in Africa has had for the rest of the world with the detection of new lineages and variants, the most recent being the characterization of various Omicron subvariants. CONCLUSION Sustained investment for diagnostics and genomic surveillance in Africa is needed as the virus continues to evolve. This is important not only to help combat SARS-CoV-2 on the continent but also because it can be used as a platform to help address the many emerging and reemerging infectious disease threats in Africa. In particular, capacity building for local sequencing within countries or within the continent should be prioritized because this is generally associated with shorter turnaround times, providing the most benefit to local public health authorities tasked with pandemic response and mitigation and allowing for the fastest reaction to localized outbreaks. These investments are crucial for pandemic preparedness and response and will serve the health of the continent well into the 21st century